| Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy BP Vickery, AM Scurlock, M Kulis, PH Steele, J Kamilaris, JP Berglund, ... Journal of allergy and clinical immunology 133 (2), 468-475. e6, 2014 | 453 | 2014 |
| Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation … J Bousquet, HJ Schünemann, A Togias, C Bachert, M Erhola, PW Hellings, ... Journal of Allergy and Clinical Immunology 145 (1), 70-80. e3, 2020 | 428 | 2020 |
| Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers MH Shamji, SR Durham Journal of Allergy and Clinical Immunology 140 (6), 1485-1498, 2017 | 416 | 2017 |
| Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper MH Shamji, JH Kappen, M Akdis, E Jensen‐Jarolim, EF Knol, ... Allergy 72 (8), 1156-1173, 2017 | 407 | 2017 |
| Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies LK James, MH Shamji, SM Walker, DR Wilson, PA Wachholz, JN Francis, ... Journal of Allergy and Clinical Immunology 127 (2), 509-516. e5, 2011 | 378 | 2011 |
| Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the … I Agache, J Beltran, C Akdis, M Akdis, C Canelo‐Aybar, GW Canonica, ... Allergy 75 (5), 1023-1042, 2020 | 315 | 2020 |
| Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy MH Shamji, C Ljørring, JN Francis, M A Calderon, M Larche, I Kimber, ... Allergy 67 (2), 217-226, 2012 | 314 | 2012 |
| Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3‐expressing cells and elevated allergen‐specific immunoglobulin G4, immunoglobulin A and … GW Scadding, MH Shamji, MR Jacobson, DI Lee, D Wilson, MT Lima, ... Clinical & Experimental Allergy 40 (4), 598-606, 2010 | 307 | 2010 |
| IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens AF Santos, LK James, HT Bahnson, MH Shamji, NC Couto-Francisco, ... Journal of Allergy and Clinical Immunology 135 (5), 1249-1256, 2015 | 265 | 2015 |
| Allergen immunotherapy in children user’s guide M Alvaro‐Lozano, CA Akdis, M Akdis, C Alviani, E Angier, S Arasi, ... Pediatric allergy and immunology 31, 1-101, 2020 | 261 | 2020 |
| EAACI Biologicals Guidelines—Recommendations for severe asthma I Agache, CA Akdis, M Akdis, GW Canonica, T Casale, T Chivato, ... Allergy 76 (1), 14-44, 2021 | 236 | 2021 |
| Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy M Lao-Araya, E Steveling, GW Scadding, SR Durham, MH Shamji Journal of Allergy and Clinical Immunology 134 (5), 1193-1195. e4, 2014 | 218 | 2014 |
| Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal … GW Scadding, MA Calderon, MH Shamji, AO Eifan, M Penagos, F Dumitru, ... Jama 317 (6), 615-625, 2017 | 217 | 2017 |
| Mechanisms of immunotherapy to aeroallergens MH Shamji, SR Durham Clinical & experimental allergy 41 (9), 1235-1246, 2011 | 203 | 2011 |
| 2019 ARIA Care pathways for allergen immunotherapy J Bousquet, O Pfaar, A Togias, HJ Schünemann, I Ansotegui, ... Allergy 74 (11), 2087-2102, 2019 | 202 | 2019 |
| Immunology of COVID‐19: mechanisms, clinical outcome, diagnostics, and perspectives—a report of the European Academy of Allergy and Clinical Immunology (EAACI) M Sokolowska, ZM Lukasik, I Agache, CA Akdis, D Akdis, M Akdis, ... Allergy 75 (10), 2445-2476, 2020 | 190 | 2020 |
| Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response K Golebski, JA Layhadi, U Sahiner, EH Steveling-Klein, MM Lenormand, ... Immunity 54 (2), 291-307. e7, 2021 | 167 | 2021 |
| The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses MH Shamji, LK Wilcock, PA Wachholz, RJ Dearman, I Kimber, ... Journal of immunological methods 317 (1-2), 71-79, 2006 | 165 | 2006 |
| Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI Guidelines … I Agache, C Rocha, J Beltran, Y Song, M Posso, I Solà, P Alonso‐Coello, ... Allergy 75 (5), 1043-1057, 2020 | 162* | 2020 |
| EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines M Sokolowska, T Eiwegger, M Ollert, MJ Torres, D Barber, S Del Giacco, ... Allergy 76 (6), 1629-1639, 2021 | 160 | 2021 |
